Article Text

Download PDFPDF
Staged gamma knife radiosurgery for large critically located benign meningiomas: evaluation of a series comprising 20 patients
  1. K Haselsberger1,
  2. T Maier1,
  3. K Dominikus2,
  4. E Holl1,
  5. S Kurschel1,
  6. P Ofner-Kopeinig3,
  7. F Unger1
  1. 1
    Department of Neurosurgery, Medical University, Graz, Austria
  2. 2
    Department of Therapeutic Radiology and Oncology, Medical University, Graz, Austria
  3. 3
    Institute for Medical Informatics, Statistics and Documentation, Medical University, Graz, Austria
  1. Correspondence to Professor K Haselsberger, Department of Neurosurgery, Medical University, Auenbruggerplatz 29, 8036 Graz, Austria; klaus.haselsberger{at}


Objectives: This study investigated the efficacy of staged radiosurgical treatment for intracranial meningiomas exceeding 3 cm in diameter.

Methods: Between April 1992 and May 2008, staged gamma knife radiosurgery was performed in 20 patients with large benign meningiomas. 14 patients had undergone surgery at least once. The patients’ ages ranged between 26 and 73 years (median 60.5). Tumour volumes measured between 13.6 and 79.8 cm3 (median 33.3) and treatment volumes between 5.4 and 42.9 cm3 (median 19.0). Of 41 treatments, the prescription dose at the tumour margin was 12 Gy for 33 treatments, 10 Gy for one treatment, 14 Gy for four treatments, 15 Gy for one treatment and 25 Gy for a further two treatments (median 12 Gy to a marginal isodose of 45%). Median follow-up was 7.5 years.

Results: Tumour control was achieved in 90% of our series (25% tumour regression, 65% stable size). Two patients (10%) experienced tumour progression outlying the planning target volumes treated by an additional radiosurgical procedure. Thereafter tumour volume decreased in one patient and remained stable in the second one. Clinically, nine patients (45%) improved within the time of follow-up and 11 (55%) remained unchanged.

Conclusion: As a result of excellent tumour control at a low concomitant morbidity, staged radiosurgical treatment for meningiomas represents a safe treatment modality that can be recommended for meningiomas in critical locations either after incomplete surgery or as primary treatment for patients with significant comorbidity.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Competing interests None.

  • Provenance and Peer review Not commissioned; externally peer reviewed.